Cargando…

Physicians’ Perceptions of Their Patients’ Attitude and Knowledge of Long-Term Oral Anticoagulant Therapy in Bulgaria

Background and Objectives: Oral anticoagulation (OAC) is widely used in daily clinical practice worldwide for various indications. We aimed to explore the perception of Bulgarian clinicians about their patients’ attitude and knowledge of long-term OAC, prescribed for atrial fibrillation (AF) and/or...

Descripción completa

Detalles Bibliográficos
Autores principales: Runev, Nikolay, Potpara, Tatjana, Naydenov, Stefan, Vladimirova, Anita, Georgieva, Gergana, Manov, Emil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681397/
https://www.ncbi.nlm.nih.gov/pubmed/31248007
http://dx.doi.org/10.3390/medicina55070313
_version_ 1783441723211382784
author Runev, Nikolay
Potpara, Tatjana
Naydenov, Stefan
Vladimirova, Anita
Georgieva, Gergana
Manov, Emil
author_facet Runev, Nikolay
Potpara, Tatjana
Naydenov, Stefan
Vladimirova, Anita
Georgieva, Gergana
Manov, Emil
author_sort Runev, Nikolay
collection PubMed
description Background and Objectives: Oral anticoagulation (OAC) is widely used in daily clinical practice worldwide for various indications. We aimed to explore the perception of Bulgarian clinicians about their patients’ attitude and knowledge of long-term OAC, prescribed for atrial fibrillation (AF) and/or known deep venous thrombosis (DVT)/pulmonary embolism (PE). Materials and Methods: We performed a cross-sectional study that involved 226 specialists: 187 (82.7%) cardiologists, 23 (10.2%) neurologists, and 16 (7.1%) vascular surgeons. They filled in a questionnaire, specially designed for our study, answering various questions regarding OAC treatment in their daily clinical practice. Results: The mean prescription rate of OACs in AF patients was 80.3% and in DVT/PE—88.6%. One hundred and eighty-seven (82.7%) of the participants stated they see their patients on OAC at least once per month. According to more than one-third of the inquired clinicians, the patients did not understand well enough the provided information concerning net clinical benefit of OAC treatment. About 68% of the clinicians declared that their patients would prefer a “mutual” approach, discussing with the physician the OAC options and taking together the final decision, whereas according to 43 (19.0%), the patients preferred the physician to take a decision for them. Patients’ OAC treatment had been interrupted at least once within the last year due to a physician’s decision by 178 (78.8%) of the participants and the most common reason was elective surgery. The most influential factors for a patient’s choice of OAC were the need of a specific diet to be kept, intake frequency, and possible adverse reactions. Conclusions: Our results suggest that a clinician’s continuous medical education, shared decision-making, and appropriate local strategies for improved awareness of AF/DVT/PE patients are key factors for improvement of OAC management.
format Online
Article
Text
id pubmed-6681397
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66813972019-08-09 Physicians’ Perceptions of Their Patients’ Attitude and Knowledge of Long-Term Oral Anticoagulant Therapy in Bulgaria Runev, Nikolay Potpara, Tatjana Naydenov, Stefan Vladimirova, Anita Georgieva, Gergana Manov, Emil Medicina (Kaunas) Article Background and Objectives: Oral anticoagulation (OAC) is widely used in daily clinical practice worldwide for various indications. We aimed to explore the perception of Bulgarian clinicians about their patients’ attitude and knowledge of long-term OAC, prescribed for atrial fibrillation (AF) and/or known deep venous thrombosis (DVT)/pulmonary embolism (PE). Materials and Methods: We performed a cross-sectional study that involved 226 specialists: 187 (82.7%) cardiologists, 23 (10.2%) neurologists, and 16 (7.1%) vascular surgeons. They filled in a questionnaire, specially designed for our study, answering various questions regarding OAC treatment in their daily clinical practice. Results: The mean prescription rate of OACs in AF patients was 80.3% and in DVT/PE—88.6%. One hundred and eighty-seven (82.7%) of the participants stated they see their patients on OAC at least once per month. According to more than one-third of the inquired clinicians, the patients did not understand well enough the provided information concerning net clinical benefit of OAC treatment. About 68% of the clinicians declared that their patients would prefer a “mutual” approach, discussing with the physician the OAC options and taking together the final decision, whereas according to 43 (19.0%), the patients preferred the physician to take a decision for them. Patients’ OAC treatment had been interrupted at least once within the last year due to a physician’s decision by 178 (78.8%) of the participants and the most common reason was elective surgery. The most influential factors for a patient’s choice of OAC were the need of a specific diet to be kept, intake frequency, and possible adverse reactions. Conclusions: Our results suggest that a clinician’s continuous medical education, shared decision-making, and appropriate local strategies for improved awareness of AF/DVT/PE patients are key factors for improvement of OAC management. MDPI 2019-06-26 /pmc/articles/PMC6681397/ /pubmed/31248007 http://dx.doi.org/10.3390/medicina55070313 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Runev, Nikolay
Potpara, Tatjana
Naydenov, Stefan
Vladimirova, Anita
Georgieva, Gergana
Manov, Emil
Physicians’ Perceptions of Their Patients’ Attitude and Knowledge of Long-Term Oral Anticoagulant Therapy in Bulgaria
title Physicians’ Perceptions of Their Patients’ Attitude and Knowledge of Long-Term Oral Anticoagulant Therapy in Bulgaria
title_full Physicians’ Perceptions of Their Patients’ Attitude and Knowledge of Long-Term Oral Anticoagulant Therapy in Bulgaria
title_fullStr Physicians’ Perceptions of Their Patients’ Attitude and Knowledge of Long-Term Oral Anticoagulant Therapy in Bulgaria
title_full_unstemmed Physicians’ Perceptions of Their Patients’ Attitude and Knowledge of Long-Term Oral Anticoagulant Therapy in Bulgaria
title_short Physicians’ Perceptions of Their Patients’ Attitude and Knowledge of Long-Term Oral Anticoagulant Therapy in Bulgaria
title_sort physicians’ perceptions of their patients’ attitude and knowledge of long-term oral anticoagulant therapy in bulgaria
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681397/
https://www.ncbi.nlm.nih.gov/pubmed/31248007
http://dx.doi.org/10.3390/medicina55070313
work_keys_str_mv AT runevnikolay physiciansperceptionsoftheirpatientsattitudeandknowledgeoflongtermoralanticoagulanttherapyinbulgaria
AT potparatatjana physiciansperceptionsoftheirpatientsattitudeandknowledgeoflongtermoralanticoagulanttherapyinbulgaria
AT naydenovstefan physiciansperceptionsoftheirpatientsattitudeandknowledgeoflongtermoralanticoagulanttherapyinbulgaria
AT vladimirovaanita physiciansperceptionsoftheirpatientsattitudeandknowledgeoflongtermoralanticoagulanttherapyinbulgaria
AT georgievagergana physiciansperceptionsoftheirpatientsattitudeandknowledgeoflongtermoralanticoagulanttherapyinbulgaria
AT manovemil physiciansperceptionsoftheirpatientsattitudeandknowledgeoflongtermoralanticoagulanttherapyinbulgaria